Advancements in Chronic Wound Care: Scarletred®Vision Revolutionizes Assessment

Wound healing is a complex biological process that can be broadly classified into two main categories: acute and chronic wounds. Acute wounds typically result from a sudden injury or trauma, and generally follow a predictable and timely healing process. Chronic wounds, on the other hand, are characterized by delayed or stalled healing beyond three months and often require specialized care to prevent complications. As the prevalence of chronic wounds increases due to an aging and multimorbid population, advances in wound care, management and assessment of tissue composition have become increasingly important to improve patient outcomes and quality of life (QoL).

Chronic Wound Classification and Assessment

Chronic wounds pose a significant challenge to healthcare professionals due to their prolonged healing times and increased susceptibility to infections. They are categorized into venous, arterial, diabetic, and pressure ulcers. They are particularly common in an elderly, immobile and/or multimorbid population. During assessment, the wound location, size, and depth, as well as tissue type needs to be documented. In recent years, the field of wound care has seen notable advancements aimed at optimizing the treatment of chronic wounds. One such innovation is Scarletred®Vision, which integrates its technology to provide more accurate and timely assessments of wound size and tissue composition to provide personalized treatment. Effective chronic wound care involves a comprehensive approach that addresses underlying factors contributing to delayed healing, such as impaired blood flow, infection, or comorbidities like diabetes. This approach enables healthcare providers to analyze the success of treatment for each patient, leading to more effective and personalized care.

Scarletred®Vision: Transforming Chronic Wound Managment

Scarletred®Vision is at the forefront of this technological evolution in chronic wound care. This innovative system offers a non-invasive and efficient solution for quantifying size and classifying tissue composition, such as in diabetic wounds. Unlike traditional methods that rely on manual measurements or subjective estimates, Scarletred®Vision utilizes advanced AI-based imaging technology to provide precise and objective data. Providing accurate evaluations can influence treatment strategy and increase an individual’s QoL.

The system employs a smartphone application and AI algorithms to analyze images of the wound, offering detailed insights into its dimensions and the composition of surrounding tissues as follows:

• Necrosis with infection
• Necrosis without infection
• Fibrin
• Granulation
• Bone or tendon
• Epithelialization
• Erosion
• Hyperkeratosis
• Macerated skin

‍

This data is invaluable for healthcare professionals in designing targeted treatment plans and monitoring the progress of chronic wounds over time.

‍

‍

‍Benefits of Scarletred®Vision

• Accurate Size Measurement: Scarletred®Vision eliminates the margin of error associated with manual measurements, providing healthcare workers and patients with reliable and consistent data on wound size. This precision is crucial for tracking healing progress and adjusting treatment strategies accordingly.‍
• Tissue Composition Analysis: The system goes beyond mere size measurement by offering insights into tissue composition. This includes information on inflammation, granulation tissue formation, and other factors influencing the wound healing process. Such detailed data allows for a more nuanced understanding of the wound environment.‍
• Remote Monitoring and Collaboration: Scarletred®Vision's digital capabilities facilitate remote monitoring, enabling healthcare professionals to assess wounds and collaborate on treatment plans. This is especially beneficial for patients with mobility issues or in rural areas who may have limited access to specialized wound care.

‍

Other examples for chronic wounds

Other wound related disease include Pyoderma gangrenosum. This condition is associated with chronic inflammatory conditions such as Ulcerative colitis, Crohn’s disease, chronic polyarthritis as well as myeloproliferative diseases. Pyoderma gangrenosum (PG) usually develops from an initial trauma due to autoimmune issues and is also present in a younger patient group. Treatment includes immunosuppressive therapy and glucocorticosteroids while close monitoring is essential. 

As chronic wounds continue to present a significant healthcare challenge, innovations like Scarletred®Vision are instrumental in advancing chronic wound care and management. The integration of technology not only enhances accuracy in assessing wounds but also allows for more personalized and efficient treatment strategies. With ongoing developments in the field, these advancements hold the promise of improving the QoL for individuals affected by chronic wounds.

‍